HSD17B11 Antikörper (AA 201-300)

Produktnummer ABIN6989209

Produktdetails anti-HSD17B11 Antikörper

Target: HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))

Bindungsspezifität: AA 201-300

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser HSD17B11 Antikörper ist unkonjugiert

Applikation: ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Ratte

Homologie: Human,Mouse,Cow,Sheep,Pig,Horse,Rabbit

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human Hsd17b11

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200
ICC 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Haltbarkeit: 12 months

Details zu HSD17B11

Target: HSD17B11 (Hydroxysteroid (17-Beta) Dehydrogenase 11 (HSD17B11))

Andere Bezeichnung: HSD17B11 (HSD17B11 Produkte)

Synonyme: 17BHSD11 antikoerper, DHRS8 antikoerper, PAN1B antikoerper, RETSDR2 antikoerper, SDR16C2 antikoerper, Dhrs8 antikoerper, HSD17B13 antikoerper, MGC84756 antikoerper, HSD17B11 antikoerper, Pan1b antikoerper, SDR2 antikoerper, retSDR2 antikoerper, 17-beta-HSD 11 antikoerper, 17-beta-HSD XI antikoerper, 17bHSD11 antikoerper, 17betaHSD11 antikoerper, 17betaHSDXI antikoerper, hydroxysteroid 17-beta dehydrogenase 11 antikoerper, hydroxysteroid (17-beta) dehydrogenase 11 antikoerper, hydroxysteroid (17-beta) dehydrogenase 11 L homeolog antikoerper, estradiol 17-beta-dehydrogenase 11 antikoerper, HSD17B11 antikoerper, Hsd17b11 antikoerper, hsd17b11.L antikoerper, hsd17b11 antikoerper, LOC100348005 antikoerper, LOC100520923 antikoerper

Hintergrund:

Synonyms: 17 beta HSD 11, 17 beta HSD XI, 17 BETA HSD11, 17 BETA HSDXI, 17 beta hydroxysteroid dehydrogenase 11, 17 beta hydroxysteroid dehydrogenase type XI, 17 beta hydroxysteroid dehydrogenase XI, 17-beta-HSD 11, 17-beta-HSD XI, 17-beta-hydroxysteroid dehydrogenase 11, 17-beta-hydroxysteroid dehydrogenase XI, 17betaHSD11, 17betaHSDXI, 17bHSD11, CTCL associated antigen HD CL 03, CTCL tumor antigen HD CL 03, CTCL-associated antigen HD-CL-03, Cutaneous T cell lymphoma associated antigen HD CL 03, Cutaneous T-cell lymphoma-associated antigen HD-CL-03, Dehydrogenase/reductase SDR family member 8, DHB11_HUMAN, DHRS8, Estradiol 17 beta dehydrogenase 11, Estradiol 17-beta-dehydrogenase 11, Hsd17b11, Hydroxysteroid (17 beta) dehydrogenase 11, PAN1B, Retinal short chain dehydrogenase/reductase 2, Retinal short-chain dehydrogenase/reductase 2, RETSDR2, SDR16C2, SDR2, Short chain dehydrogenase/reductase family 16C member 2, T cell lymphoma associated antigen HD CL 03, 17_-HSD11.

Background: Can convert androstan-3-alpha,17-beta-diol (3-alpha-diol) to androsterone in vitro, suggesting that it may participate in androgen metabolism during steroidogenesis. May act by metabolizing compounds that stimulate steroid synthesis and/or by generating metabolites that inhibit it. Has no activity toward DHEA (dehydroepiandrosterone), or A-dione (4-androste-3,17-dione), and only a slight activity toward testosterone to A-dione. Tumor-associated antigen in cutaneous T-cell lymphoma.

Gen-ID: 51170

UniProt: Q8NBQ5